Cyclopharm Limited Price Chart
Cyclopharm Limited CYC.XA Financial and Trading Overview
| Cyclopharm Limited stock price | 1.65 AUD |
| Previous Close | 2 AUD |
| Open | 1.95 AUD |
| Bid | 1.94 AUD x N/A |
| Ask | 1.99 AUD x N/A |
| Day's Range | 1.95 - 1.95 AUD |
| 52 Week Range | 1.06 - 2.15 AUD |
| Volume | 585 AUD |
| Avg. Volume | 794 AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.814559 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.056 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CYC.XA Valuation Measures
| Enterprise Value | 170.14M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.961832 |
| Enterprise Value/Revenue | 6.846 |
| Enterprise Value/EBITDA | -31.766 |
Trading Information
Cyclopharm Limited Stock Price History
| Beta (5Y Monthly) | 0.814559 |
| 52-Week Change | 88.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.15 AUD |
| 52 Week Low | 1.06 AUD |
| 50-Day Moving Average | 1.58 AUD |
| 200-Day Moving Average | 1.58 AUD |
CYC.XA Share Statistics
| Avg. Volume (3 month) | 794 AUD |
| Avg. Daily Volume (10-Days) | 794 AUD |
| Shares Outstanding | N/A |
| Float | 55.7M |
| Short Ratio | N/A |
| % Held by Insiders | 54.23% |
| % Held by Institutions | 5.91% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.01 |
| Trailing Annual Dividend Yield | 0.50% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -26.60% |
| Operating Margin (ttm) | -24.13% |
| Gross Margin | 70.06% |
| EBITDA Margin | -21.55% |
Management Effectiveness
| Return on Assets (ttm) | -7.12% |
| Return on Equity (ttm) | -16.61% |
Income Statement
| Revenue (ttm) | 24.85M AUD |
| Revenue Per Share (ttm) | 0.27 AUD |
| Quarterly Revenue Growth (yoy) | 16.69% |
| Gross Profit (ttm) | 17.41M AUD |
| EBITDA | -5356166 AUD |
| Net Income Avi to Common (ttm) | -6611515 AUD |
| Diluted EPS (ttm) | -0.056 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.3M AUD |
| Total Cash Per Share (mrq) | 0.22 AUD |
| Total Debt (mrq) | 4.33M AUD |
| Total Debt/Equity (mrq) | 11.86 AUD |
| Current Ratio (mrq) | 4.646 |
| Book Value Per Share (mrq) | 0.393 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6664485 AUD |
| Levered Free Cash Flow (ttm) | -5969164 AUD |
Profile of Cyclopharm Limited
| Country | Australia |
| State | NSW |
| City | Kingsgrove |
| Address | 1 The Crescent |
| ZIP | 2208 |
| Phone | 61 2 9541 0411 |
| Website | https://www.cyclopharm.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 63 |
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Q&A For Cyclopharm Limited Stock
What is a current CYC.XA stock price?
Cyclopharm Limited CYC.XA stock price today per share is 1.65 AUD.
How to purchase Cyclopharm Limited stock?
You can buy CYC.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cyclopharm Limited?
The stock symbol or ticker of Cyclopharm Limited is CYC.XA.
How many shares does Cyclopharm Limited have in circulation?
The max supply of Cyclopharm Limited shares is 0.
What is Cyclopharm Limited Price to Earnings Ratio (PE Ratio)?
Cyclopharm Limited PE Ratio is now.
What was Cyclopharm Limited earnings per share over the trailing 12 months (TTM)?
Cyclopharm Limited EPS is -0.056 AUD over the trailing 12 months.